1034266-14-2

Basic information

• Product Name: 1-(4-broMo-2-fluorophenyl)ethanaMine
• Synonyms: 1-(4-broMo-2-fluorophenyl)ethanaMine;4-Bromo-2-fluoro-alpha-methylbenzenemethanamine;1-(4-bromo-2-fluorophenyl)ethan-1-amine
• CAS NO: 1034266-14-2
• Molecular Formula: C8H9BrFN
• Molecular Weight: 218.0661632
• Mol File: 1034266-14-2.mol

Chemical Properties

• Boiling Point: 250℃
• Flash Point: 105℃
• Appearance: /
• Density: 1.482
• CAS DataBase Reference: 1-(4-broMo-2-fluorophenyl)ethanaMine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-broMo-2-fluorophenyl)ethanaMine(1034266-14-2)
• EPA Substance Registry System: 1-(4-broMo-2-fluorophenyl)ethanaMine(1034266-14-2)

Safety Data

• Hazardous Substances Data: 1034266-14-2(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
1-(4-bromo-2-fluorophenyl)ethanamine is used as a building block in organic synthesis for the creation of various bioactive compounds. Its unique structure allows for the development of new molecules with potential applications in different industries.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-(4-bromo-2-fluorophenyl)ethanamine serves as a starting material for the preparation of new drugs. Its aromatic amine structure and the presence of bromine and fluorine atoms make it a valuable component in the development of novel therapeutic agents.
Used in Agrochemicals:
1-(4-bromo-2-fluorophenyl)ethanamine may also be utilized as a starting material in the development of new agrochemicals, such as pesticides or herbicides. Its chemical properties can be harnessed to create effective compounds for agricultural applications.
Safety Considerations:
Due to the potential biological activity of 1-(4-bromo-2-fluorophenyl)ethanamine, it is crucial to handle this compound with care and adhere to proper safety protocols when working with it in a laboratory setting. This ensures the safety of researchers and the environment.

Upstream product

• 1034266-11-9 C-azido-C-(2-fluoro-4-bromo-phenyl)-methylamine 
• 75-16-1 methylmagnesium bromide 
• 105942-08-3 4-bromo-6-fluorobenzonitrile 

Relevant articles and documents

3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH

The invention is directed to a formula (I), or a pharmamceutically acceptable salt thereof, wherein R1, R2a, R2b and R3-R7 are herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer.

Haloalkyl-substituted amides as insecticides and acaricides

The present invention relates to halogen-substituted amide derivatives of the general formula (I)in which R1 to R6, Q1 to Q8, A, V, W, X, Y, n and m are each defined as described in the descriptionand to a process for preparation thereof and to the use th

CB1 RECEPTOR MODULATORS

Compounds of formula (I) suppress the normal signalling activity CB1 receptors, and are thus useful in the treatment of diseases or conditions which are mediated by CB1 receptor signalling activity, such as treatment of obesity and overweight, prevention

Efficient synthesis of chiral phenethylamines: preparation, asymmetric hydrogenation, and mild deprotection of ene-trifluoroacetamides

A mild and efficient route to enantioenriched aryl alkyl amines from ketones has been developed. The first successful synthesis and asymmetric hydrogenation of ene-trifluoroamides from oximes gave highly enantioenriched trifluoroacetamides (94-98% ee). The corresponding phenethyl amides are liberated under mild conditions (K2CO3, MeOH/H2O). In addition, a new application of Josiphos ligands toward the asymmetric hydrogenation of both ene-acetamides and ene-trifluoroacetamides was discovered.